Biobeat already integrated into 14 Israeli isolation departments for COVID-19 patients

Biobeat, an end-to-end medical grade monitoring system for the management of patients and individuals from a distance is currently being utilised in 14 Israeli hospitals as the main monitoring solution in COVID-19 isolation units as part of the effort by the Israeli Ministry of Health to combat

...

Aircraft Carrier Outbreak Sends Troops Scrambling

Story from Daily Beast

U.S. Navy and Marine Corps service members in Guam were ordered on Wednesday to break their own quarantine to set up makeshift shelters for U.S. troops coming off a nuclear-powered aircraft carrier, where an outbreak of the novel coronavirus is rapidly

...

Nuclear Scientists Are Working on Faster, Cheaper Covid-19 Test

Story from Bloomburg

Nuclear scientists in Austria are closing in on coronavirus testing kits that could dramatically lower the cost and time it takes to diagnose people for the disease. With Covid-19 tests in short supply in many places, some individuals have turned to private

...

bioMérieux receives Emergency Use Authorization for BIOFIRE COVID-19 test

bioMérieux, a world leader in the field of in vitro diagnostics, today announced that its subsidiary, BioFire Defense, has received Emergency Use Authorization by the U.S. Food and Drug Administration of its BIOFIRE COVID-19 test for use in CLIA moderate and high complexity clinical

...

Less Than Patient Zero

We’ve been fairly quiet about COVID here, largely because any reporting is quickly over taken by events. Scientific advice has remained fairly consistent, but how that is applied nationally and the impact of rising rates of infection is hugely variable.

Inovio Receives $5M Grant for COVID-19 Vaccine Delivery Device

INOVIO Pharmaceuticals, Inc. (NASDAQ:INO) announced today that it has received a new $5 million grant from the Bill & Melinda Gates Foundation to accelerate the testing and scale up of CELLECTRA® 3PSP proprietary smart device for the intradermal delivery of INO-4800, a DNA vaccine for

...

Coriolis Micro Air Sampler Currently Used in Asia to Collect Coronavirus Samples

Coriolis µ is an innovative biological air sampler for bio-contamination assessment, mainly dedicated to air quality control and air quality monitoring in environmental and pollution research, the pharmaceutical, food and veterinary industries, in biomedical and health environments, and so on.

...

Updated COVID-19 Resources

The  Disaster Information Management Research Center ...

ERVEBO Now Registered in Four African Countries

Merckhas confirmed that ERVEBO has now been registered by National Health Authorities in the following countries in Africa – DRC, Burundi, Ghana, and Zambia. 

ERVEBO was granted a conditional marketing authorization by the European Commission on November 11, 2019 and approved by

...

Irish Innovation in Wipes and Masks Could Help Battle Emerging Coronavirus Crisis

“What we have developed is like a living Velcro that removes and traps pathogens”

Nature-inspired wipes and masks which could capture and trap the Wuhan Coronavirus (2019-nCoV) are being developed by scientists at the Irish company Aquila Bioscience. This technology can be used

...

Ebola vaccine safety to be studied 5 years post vaccination

The Partnership for Research on Ebola Vaccination (PREVAC) has launched a project called PREVAC-UP with the aim of evaluating three Ebola vaccine regimens for five years after vaccination.

The study will assess several factors of these treaments

  • long-term
...

Paratek Awarded BARDA Project BioShield Contract for NUZYRA

Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, has announced that the Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response (ASPR),

...

Emergex Vaccine Candidate for Francisella Tularensis

Emergex Vaccines Holding Limited (‘Emergex’), a biotechnology company developing set-point vaccines to prevent serious infectious diseases, has  announced the successful completion of the first step in the development of a candidate vaccine for the Gram-negative intracellular

...

Another Monkeypox case in the UK

On Tuesday December 3rd a patient was admitted to a specialist unit at St Thomas' Hospital in central London after Public Health England confirmed a diagnosis of Monkeypox. 

It is believed the individual contracted the virus whilst visting Nigeria, which has seen at least four

...

Pneumonic Plague Diagnosed in Beijing

Two people have been diagnosed with Pneumonic Plague in Beijing’s Chaoyang district, both are currently in an unamed hospital and receiving treament. 

Chaoyang Hospital, where the two patients were initially treated, has taken the measure of replacing all the chairs at its

...

Merck's Ebola Vaccine Granted Conditional Approval in the EU

Merck , known as MSD outside the United States and Canada, today announced that the European Commission has granted a conditional marketing authorization to ERVEBO for active immunization of individuals 18 years of age or older to protect against Ebola Virus Disease (EVD) caused by Zaire Ebola

...

GSK agrees to divest rabies and tick-borne encephalitis vaccines to Bavarian Nordic

GlaxoSmithKline plc has announced the divestment of travel vaccines Rabipur (tradename Rabavert in the US) for the prevention of rabies, and Encepur for the prevention of tick-borne encephalitis, to Bavarian Nordic.

The decision to divest these brands, acquired from Novartis in 2015 as

...

FDA Clears First Rapid Diagnostic Test for Ebola

The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) on Thursday allowed the marketing of the first rapid diagnostic test for the Ebola virus that has not been authorized via the agency’s Emergency Use Authorization (EUA) pathway.
...

Ebola Therapy mAb114 Receives $14 million in Funding

It was annonuced on September 24th that the Biomedical Advanced Research and Development Authority (BARDA) intends to provide $14 millio, as well as expertise support for the advanced development of an investigational Ebola treatment being pursued by Ridgeback Biotherapeutics of

...

FDA Approve Smallpox/Monkeypox Vaccine

The FDA has approved the Jynneos vaccine by Bavarian Nordic for the prevention of Smallpox and Monkeypox in adults 18 years of age and older determined to be at high risk for these infections.

Jynneos is a live vaccine produced from the strain Modified Vaccinia Ankara-Bavarian Nordic

...

Biofactura Awarded $67.4 Million to Develop Smallpox Biodefense Therapeutic

BioFactura, Inc. announced on September 26th a contract awarded by the Biomedical Advanced Research and Development Authority (BARDA) valued at up to $67.4 million for the advanced development of its Smallpox Biodefense Therapeutic as a potential medical countermeasure (MCM) for the treatment

...

Bertin Announce 2 Newcomers for Biological Threat Sampling

Bertin’s teams are proud to announce the release of 2 new air sampling equipment for biological air monitoring or biological recognition missions:

– The Coriolis Compact: dry cyclonic collector intended for air monitoring in a biological threat context.

– The Coriolis Nano:

...

Explosion at VECTOR Laboratory

Monday, September 16th, saw reports emerge of an explosion at the Russian State Research Center of Virology and Biotechnology, known as Vector.

Ebola Bombali Detected in Guinea

Researchers from The University of California, Davis, have recenctly publsihed their findings regarding the discovery of the sitxth ebolavirus, Bombali, in Angolan free-tailed bats roosting inside people’s houses in Guéckedou and Kissidougou, Guinea. 

The team from UC

...

Defence Minister calls Bioterrorism a Contagious Plague

Speaking at the Shanghai Cooperation Organisation's (SCO) First Military Medicine Conference this week, India's Defence Minister Rajnath Singh referred to bioterrorism as a 'contagious plague', and called upon the Armed Forces Medical Services (AFMS) of the SCO countries to

...

Man Pleads Guilty to Ricin Plot

A man from Los Angeles pleaded guilty this week to Federal charges of attempting to obtain ricin for unlawful purposes, namely to poison his wife!

Over a two-month period late last year, Steve S. Kim attempted to obtain ricin from what he thought was an online seller, but in fact was an

...

Tearaway Tularemia

UPDATE: Case numbers have now reached over 800. 

Sweden is continuing to see an increase in the number of people affected by Tularemia this year.

At present there have been around 700 cases reported, and we are only just entering September. This is a much higher number than

...

HHS Purchases Additional Smallpox Vaccine for SNS

The U.S. Department of Health and Human Services (HHS) announced this week that they will be purchasing a smallpox vaccine, called ACAM2000, to build and replenish vaccine stored in the ...

HHS Funds an Additional Year of Ebola Vaccine Manufacturing

As part of the international response to the Ebola virus outbreak in the Democratic Republic of the Congo (DRC) and to meet domestic biodefense goals, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) will support

...

CDC Shuts Down USAMRIID Lab

Following an inspection in June, the CDC has issued a cease-and-desist order to the Fort Detrick biodefense lab. All research at the lab, run by the Army Medical Research Institute of Infectious Diseases (USAMRIID), is now on hold until further notice. 

The cease-and-desist

...

GeoVax Announces 100% Protection Data from Marburg Virus Vaccine Study

GeoVax Labs, Inc.has announced positive results (100% protection) from preclinical challenge studies of its Marburg virus vaccine candidate; Marburg virus a critical medical threat against which there is currently no available vaccine or treatment. This study data adds to that showing similar

...

Biology professor receives $1.9 million grant from NIH to study Vaccinia virus

Zhilong Yang, an assistant professor in the Division of Biology, is the principal investigator on a new, nearly $1.9 million grant from the National Institutes of Health. The five-year project will study how vaccinia virus — a member of the poxvirus family — produces its proteins. This award is

...

Our Current Sponsors